Riskpilot← Back to searchSign inGet full accessHandaid AB
ABActiveOrg 5566887567Brostugevägen 18Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20050 employees
Revenue 2024
SEK 523K
+8% vs 2023
EBITDA margin
32.1%
+63% vs 2023
Equity ratio
92.5%
Financial strength
Net profit 2024
SEK 131K
+72% vs 2023
| Revenue | SEK 523K | +8% |
| EBITDA | SEK 168K | +63% |
| Net profit | SEK 131K | +72% |
| Total assets | SEK 3,1M | -1% |
| Equity | SEK 2,9M | -3% |
| Employees | 0 | — |
Legal name
Handaid AB
Org number
5566887567
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
26 oktober 2005
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall tillverka, sälja produkter och tillhandahålla tjänster avseende medicinsk rehabilitering samt därmed förenlig verksamhet.
Address
Brostugevägen 18
Phone
+46708252129
Email
contact@handaid.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 820 | 788 | 375 | 483 | 523 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 225 | 339 | 65 | 103 | 168 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 225 | 339 | 65 | 103 | 168 |
| Net financials | −17 | −12 | −10 | −5 | — |
| Profit before tax | 208 | 327 | 55 | 99 | 168 |
| Tax | −45 | −68 | −13 | −23 | −37 |
| Net profit | 163 | 259 | 42 | 76 | 131 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 336 | 3 622 | 3 268 | 3 122 | 3 083 |
| Equity | 3 109 | 3 191 | 3 047 | 2 938 | 2 852 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 227 | 431 | 221 | 184 | 231 |
| Total debt | 227 | 431 | 221 | 184 | 231 |
EBITDA margin
32.1%
This company
15.8%
Market median
+103% vs market
20202024
Equity ratio
92.5%
This company
38.2%
Market median
+142% vs market
20202024
Return on equity
4.6%
This company
18.4%
Market median
-75% vs market
20202024
Net profit margin
25.0%
This company
8.1%
Market median
+209% vs market
20202024
Asset turnover
0.17×
This company
1.12×
Market median
-85% vs market
20202024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AG | Audit | 2026 |
| Former (1) | ||
LM Audit | Audit | 2022 – 2026 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Handaid AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Mattias Eklöf | Audit | 0 companies |
| Alf Gunnar Rune Sjödelius | Audit | 0 companies |
| Åke Vilhelm Persson | Deputy Board Member | 0 companies |
| Margareta Elisabet Persson | Board of Directors | 0 companies |